Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Bullboard (TSXV:TLT)

View:
Comment by blackjack0on Nov 29, 2024 11:03am

RE:RE:RE:RE:RE:RE:RE:RE:Level II Quotes ! Big Drop This AM

Your true colours are showing! What new drugs are you referring to?? Please list 
Comment by DeathXray33on Nov 29, 2024 11:00am

RE:RE:RE:RE:RE:RE:RE:Level II Quotes ! Big Drop This AM

This handsome U.S. investor bought today & is going to buy next Monday. --- Thanks & Good luck --- # Tender Loving Technology
Comment by bmk211on Nov 29, 2024 10:57am

RE:RE:RE:RE:RE:RE:RE:Level II Quotes ! Big Drop This AM

Ya this is absolutely a hail mary.  Too many other drug companies have caught up.  This company fumbles around.   If it ever gets approved and continues to raise money and the ...more  
Comment by N0taP00pon Nov 29, 2024 10:34am

RE:RE:RE:RE:RE:RE:Level II Quotes ! Big Drop This AM

Very little selling in the US despite the price drop,  unlike in Canada yesterday.  Normally, I would take that as a good sign. But with this stock who knows. US investors have probably put ...more  
Comment by N0taP00pon Nov 29, 2024 10:23am

RE:Pioneering is never easy...

Ever heard of photofrin? It has been used since 1995. So PDT is not new to the FDA.  Now that that is out of the way, try and find the reason why the FDA is gun shy of approving this particular ...more  
Post by wildbird1on Nov 29, 2024 8:50am

Pioneering is never easy...

The real problem right now, is not the FDA or TLT management, the real problem is the innovative aspect of this new treatment. The FDA has never before been asked to grant BTD to such an innovative ...more  
Comment by managementfirston Nov 29, 2024 8:34am

RE:RE:RE:RE:RE:Level II Quotes ! Big Drop This AM

I hope RTW will talk about the reasons for delay next week. From yesterdays news release, RTW and Mandel talked all about the figures, seems minor job needed for resubmiting.
Comment by StevenBirchon Nov 29, 2024 7:58am

RE:RE:RE:RE:Level II Quotes ! Big Drop This AM

I say that this Black Friday nonsense has gone too far, now even TLT is at a massive discount? Hopefully cooler heads prevail and realize a little delay isn't the end of the world.
Comment by Infinityon Nov 29, 2024 3:16am

RE:RE:RE:Level II Quotes ! Big Drop This AM

What TLT lacks is clarity.  The clinical test results are all superior to existing FDA approved Treatments.  This MOM AND POP culture within the compamy  has to change for this company ...more  
Post by Oden6570on Nov 29, 2024 2:25am

Riddle me this !

I am wondering why my taxes are so fricking high here in Canada while our Government agencies are in many cases useless IMHO. Give the current phase2 results this treatment should already be approved ...more  
Comment by ChemVan9094on Nov 29, 2024 1:50am

RE:Criteria for BTD - hoping we can sell it on the last bullet

Instead of punishing myself wondering what "they" know that we don't know, placed limit bids @0.22 and 0.215, and went back to sleep -- they got filled yayyy! That's a good morning ...more  
Comment by McBullishon Nov 28, 2024 8:46pm

RE:Hey Mcmullet welcome to the red club bud

3 posts in 24hrs. I'm flattered your life is so pathetic you sit there and think about me, but Im worried you might be getting obsessed. Im buying more. It's going back up during BTD ...more  
Comment by Dumbeldorfwhiteon Nov 28, 2024 5:52pm

RE:RE:Criteria for BTD - hoping we can sell it on the last bullet

So if that's the case geniuses then why aren't people lining up left and right for this treatment, they treated 12 people a whole year. So please explain that one to me, or u just going to ...more  
Comment by Legit62on Nov 28, 2024 5:48pm

RE:RE:RE:TLT will get BTD

Dr credentials here but dealing with FDA is no easy task, your fighting the system, but that being said, if our data is as superior as is stated in all of Theralases news and data releases, we should ...more  
Comment by Sosak1on Nov 28, 2024 5:44pm

RE:Criteria for BTD - hoping we can sell it on the last bullet

Nobody comes even close to TLT treatment results.  Big Pharma and FDA working together on this. Hopfully new FDA head men will change this becase people need this. Can you imagine if there is ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250